[go: up one dir, main page]

DE69607001D1 - Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein - Google Patents

Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein

Info

Publication number
DE69607001D1
DE69607001D1 DE69607001T DE69607001T DE69607001D1 DE 69607001 D1 DE69607001 D1 DE 69607001D1 DE 69607001 T DE69607001 T DE 69607001T DE 69607001 T DE69607001 T DE 69607001T DE 69607001 D1 DE69607001 D1 DE 69607001D1
Authority
DE
Germany
Prior art keywords
dna sequence
breast
breast cancer
encoded
glance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69607001T
Other languages
English (en)
Other versions
DE69607001T2 (de
Inventor
A Watson
P Fleming
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Louis University
Washington University in St Louis WUSTL
Original Assignee
St Louis University
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Louis University, Washington University in St Louis WUSTL filed Critical St Louis University
Application granted granted Critical
Publication of DE69607001D1 publication Critical patent/DE69607001D1/de
Publication of DE69607001T2 publication Critical patent/DE69607001T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G01N33/57515—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69607001T 1995-05-31 1996-05-31 Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein Expired - Lifetime DE69607001T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/455,896 US5668267A (en) 1995-05-31 1995-05-31 Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
PCT/US1996/008235 WO1996038463A1 (en) 1995-05-31 1996-05-31 Dna sequence and encoded mammary-specific breast cancer protein

Publications (2)

Publication Number Publication Date
DE69607001D1 true DE69607001D1 (de) 2000-04-13
DE69607001T2 DE69607001T2 (de) 2000-11-02

Family

ID=23810680

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607001T Expired - Lifetime DE69607001T2 (de) 1995-05-31 1996-05-31 Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein

Country Status (22)

Country Link
US (5) US5668267A (de)
EP (1) EP0833834B1 (de)
JP (2) JP3949165B2 (de)
KR (1) KR19990022122A (de)
CN (1) CN1279051C (de)
AT (1) ATE190313T1 (de)
AU (1) AU698823B2 (de)
BR (1) BR9609270A (de)
CA (2) CA2741641C (de)
CZ (1) CZ378397A3 (de)
DE (1) DE69607001T2 (de)
DK (1) DK0833834T3 (de)
EA (1) EA001398B1 (de)
ES (1) ES2145451T3 (de)
GR (1) GR3033636T3 (de)
HU (1) HUP9900873A3 (de)
NO (1) NO975508L (de)
NZ (1) NZ309445A (de)
PL (1) PL323632A1 (de)
PT (1) PT833834E (de)
TR (1) TR199701462T1 (de)
WO (1) WO1996038463A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US6566072B1 (en) 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6423496B1 (en) 1996-01-11 2002-07-23 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU5367996A (en) * 1996-03-21 1997-10-10 Human Genome Sciences, Inc. Human endometrial specific steroid-binding factor i, ii and iii
US6174992B1 (en) 1997-03-21 2001-01-16 Human Genome Sciences, Inc. Human endometrial specific steroid-binding factor I, II and III
US6552164B1 (en) 1996-08-19 2003-04-22 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US6379671B1 (en) 1996-08-19 2002-04-30 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US7282207B1 (en) 1996-08-19 2007-10-16 Abbott Laboratories Reagents and methods useful for detecting diseases of the reproductive tissues
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
US6770435B1 (en) 1996-08-19 2004-08-03 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
AU7180198A (en) * 1996-11-12 1998-06-03 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
US6667291B2 (en) 1997-06-09 2003-12-23 Smithkline Beecham Corporation Method of detecting and treating cancer
EP1002132A4 (de) * 1997-08-05 2005-04-27 Human Genome Sciences Inc Humane sekretierte proteine
EP1023443A1 (de) * 1997-10-16 2000-08-02 Incyte Pharmaceuticals, Inc. Homolog der mammoglobin
EP1032706A1 (de) * 1997-11-18 2000-09-06 Abbott Laboratories Reagenzien und verfahren zur nachweis von brustkranheiten
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20020045165A1 (en) * 1997-12-26 2002-04-18 Patricia A. Billing-Medel Reagents and methods useful for detecting diseases of the breast
AU2342299A (en) * 1998-01-26 1999-08-09 Genquest Inc. Compositions and methods for detecting and treating breast cancer
DE19813839A1 (de) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe
US6737040B1 (en) 1998-08-04 2004-05-18 Diadexus, Inc. Method and antibody for imaging breast cancer
CA2347906A1 (en) * 1998-08-04 2000-02-17 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
US6730477B1 (en) * 1998-08-04 2004-05-04 Diadexus, Inc. Method of diagnosing, monitoring and staging breast cancer
EP1169066A4 (de) * 1998-10-02 2002-10-30 Diadexus Inc Verfahren zur diagnostik, überwachung, stadiumfeststellung, bildgebung und behandlung von gynaekologischer krebs
US7014996B1 (en) 1998-10-02 2006-03-21 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6517513B1 (en) * 1999-01-21 2003-02-11 Neomatrix, Llc Intraductal breast fluid aspiration device
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
EP1185557A1 (de) * 1999-05-28 2002-03-13 Corixa Corporation Zusammensetzungen und verfahren zur behandlung, diagnose und überwachung von brustkrebs
US6416956B1 (en) 1999-08-13 2002-07-09 George Washington University Transcription factor, BP1
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
CA2392510A1 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2002213084A1 (en) * 2000-10-11 2002-04-22 Avalon Pharmaceuticals Cancer-linked genes as targets for chemotherapy
PT1326638E (pt) 2000-10-18 2008-02-06 Glaxosmithkline Biolog Sa Vacinas contra cancros
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
WO2003076896A2 (en) * 2002-03-06 2003-09-18 Johns Hopkins University Use of biomarkers to detect breast cancer
US20050186577A1 (en) * 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7981616B2 (en) * 2004-02-27 2011-07-19 Musc Foundation For Research Development Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription
CA2623775A1 (en) 2005-09-19 2007-03-29 Veridex, Llc Methods and materials for identifying the origin of a carcinoma of unknown primary origin
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
EP2491116A4 (de) * 2009-10-22 2013-12-11 Univ Jefferson Zellbasierte antikrebszusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
KR102499664B1 (ko) * 2020-02-27 2023-02-15 주식회사 베르티스 암의 진단용 조성물
KR102499678B1 (ko) * 2020-02-27 2023-02-15 주식회사 베르티스 암의 진단용 조성물
KR102433983B1 (ko) * 2020-02-27 2022-08-23 주식회사 베르티스 암의 진단용 조성물
WO2021172923A1 (ko) * 2020-02-27 2021-09-02 ㈜베르티스 암의 진단용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298399A (en) * 1990-08-10 1994-03-29 Sapporo Breweries Limited Gene and process for producing a thermostable urease
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens

Also Published As

Publication number Publication date
NO975508L (no) 1998-03-18
PL323632A1 (en) 1998-04-14
CA2222747C (en) 2011-06-28
CA2222747A1 (en) 1996-12-05
CA2741641C (en) 2014-08-05
CN1279051C (zh) 2006-10-11
HUP9900873A2 (hu) 1999-07-28
AU5961696A (en) 1996-12-18
US5855889A (en) 1999-01-05
MX9709364A (es) 1998-08-30
JP3949165B2 (ja) 2007-07-25
DE69607001T2 (de) 2000-11-02
KR19990022122A (ko) 1999-03-25
ES2145451T3 (es) 2000-07-01
DK0833834T3 (da) 2000-07-31
NZ309445A (en) 1999-11-29
ATE190313T1 (de) 2000-03-15
AU698823B2 (en) 1998-11-05
TR199701462T1 (xx) 1998-04-21
JPH11507212A (ja) 1999-06-29
US6677428B1 (en) 2004-01-13
EA199700447A1 (ru) 1998-08-27
JP3989528B2 (ja) 2007-10-10
PT833834E (pt) 2000-08-31
HUP9900873A3 (en) 1999-11-29
GR3033636T3 (en) 2000-10-31
CN1189836A (zh) 1998-08-05
JP2007145855A (ja) 2007-06-14
US6004756A (en) 1999-12-21
NO975508D0 (no) 1997-11-28
US5668267A (en) 1997-09-16
EP0833834B1 (de) 2000-03-08
EP0833834A1 (de) 1998-04-08
CZ378397A3 (cs) 1998-06-17
US5968754A (en) 1999-10-19
EA001398B1 (ru) 2001-02-26
BR9609270A (pt) 1999-05-11
EP0833834A4 (de) 1998-06-03
WO1996038463A1 (en) 1996-12-05
CA2741641A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
DE69607001D1 (de) Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
WO2000050588A3 (en) Genes associated with diseases of the colon
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
DK0760010T3 (da) Fremgangsmåder til screening for Crohn's sygdom under anvendelse af TNF-mikrosatellit-alleler
NO20011394L (no) Mammoglobin, et sekrert brystspesifikt brystkreftprotein
AU1855401A (en) Screening method for candidate drugs
TR200501541T2 (tr) Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları
DE60025704D1 (de) Das goodpasture-antigen bindende protein
MX9806041A (es) Proteina purificada sr-p70.
NO20020329D0 (no) Antitumor antistoffer, proteiner og anvendelser derav
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
WO2000070036A3 (en) Genes expressed in hippocampus
DE60134956D1 (de) Gene differentiell experimiert in brudtkrebs
AU3956399A (en) Iga nephropathy-associated dna
UA30391A (uk) Спосіб лікування колоректального раку
WO2001079437A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 14, et polynucleotide codant pour ce polypeptide
WO2001074998A3 (en) Novel polypeptide - a human protein hydrolytic enzyme regulatory protein 10 and polynucleotide encoding it

Legal Events

Date Code Title Description
8364 No opposition during term of opposition